News on Shenzhen SiBiono Gene Technologies Co.%2CLtd from BioPortfolio.com http://www.BioPortfolio.com Consolidated Shenzhen SiBiono Gene Technologies Co.%2CLtd news from BioPortfolio.com Wed, 10 Feb 2010 06:06:31 GMT en GEO Monitor IPO Newsflash: Sichuan Kelun Pharmaceutical Co. Ltd A shareshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037600&HITNO=0&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037600&THISHREF=http://c.moreover.com/click/here.pl%3fz2537176142%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037600&HITNO=0&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037600&THISHREF=http://c.moreover.com/click/here.pl%3fz2537176142%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comResearch Oracle: HTDS announces recent business developmentshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024797&HITNO=1&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024797&THISHREF=http://c.moreover.com/click/here.pl%3fz2529190545%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024797&HITNO=1&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024797&THISHREF=http://c.moreover.com/click/here.pl%3fz2529190545%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Shenzhen Zhijun Pharmaceutical Co., Ltd.-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019321&HITNO=2&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019321&THISHREF=http://c.moreover.com/click/here.pl%3fz2526224012%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019321&HITNO=2&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019321&THISHREF=http://c.moreover.com/click/here.pl%3fz2526224012%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Shenzhen Salubris Pharmaceuticals Co., Ltd-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019322&HITNO=3&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019322&THISHREF=http://c.moreover.com/click/here.pl%3fz2526224201%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019322&HITNO=3&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019322&THISHREF=http://c.moreover.com/click/here.pl%3fz2526224201%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Hard to Treat Diseases (HTDS) Update On Various Business Developments Evaluations and Proposalshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022705&HITNO=4&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022705&THISHREF=http://c.moreover.com/click/here.pl%3fz2527813275%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022705&HITNO=4&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022705&THISHREF=http://c.moreover.com/click/here.pl%3fz2527813275%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInterest!ALERT: Shenzhen Accordance Pharmaceutical to buy Nanning Medicalhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017368&HITNO=5&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017368&THISHREF=http://c.moreover.com/click/here.pl%3fz2525097186%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017368&HITNO=5&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017368&THISHREF=http://c.moreover.com/click/here.pl%3fz2525097186%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHong Kong Trade Development Council: Shenzhen Accordance Pharmaceutical to acquire medicine business from Nanning Medicalhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4008537&HITNO=6&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4008537&THISHREF=http://c.moreover.com/click/here.pl%3fz2521572000%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4008537&HITNO=6&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4008537&THISHREF=http://c.moreover.com/click/here.pl%3fz2521572000%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: GEO Monitor IPO Newsflash: Guangdong Pibao Pharmaceutical Ltd A shareshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999565&HITNO=7&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999565&THISHREF=http://c.moreover.com/click/here.pl%3fz2517503809%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999565&HITNO=7&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999565&THISHREF=http://c.moreover.com/click/here.pl%3fz2517503809%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comResearch Oracle: Shenzhen Capital Group invests in Shanghai, one on bio-pharmaceuticalhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3993734&HITNO=8&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3993734&THISHREF=http://c.moreover.com/click/here.pl%3fz2514740079%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3993734&HITNO=8&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3993734&THISHREF=http://c.moreover.com/click/here.pl%3fz2514740079%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: China Biotech in Review: More Money Raised in China IPOs in 2009 than in the U.S.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3989002&HITNO=9&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3989002&THISHREF=http://c.moreover.com/click/here.pl%3fz2511760762%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3989002&HITNO=9&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3989002&THISHREF=http://c.moreover.com/click/here.pl%3fz2511760762%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSeeking Alpha: GEO Monitor IPO Newsflash: Hunan Hansen Pharmaceutical Co. Ltd A shareshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3971696&HITNO=10&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3971696&THISHREF=http://c.moreover.com/click/here.pl%3fz2501973089%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3971696&HITNO=10&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3971696&THISHREF=http://c.moreover.com/click/here.pl%3fz2501973089%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comResearch Oracle: Baidu, Borders, Eli Lilly, MetLife, Pfizer: U.S. Equity Movershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3931891&HITNO=11&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3931891&THISHREF=http://c.moreover.com/click/here.pl%3fz2480748922%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3931891&HITNO=11&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3931891&THISHREF=http://c.moreover.com/click/here.pl%3fz2480748922%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusinessWeek: Beike Biotechnology, Jiangsu University and Nanjing Drum Tower Hospital Receive $1.8 Million for Human Mesenchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3919611&HITNO=12&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3919611&THISHREF=http://c.moreover.com/click/here.pl%3fz2473559799%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3919611&HITNO=12&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3919611&THISHREF=http://c.moreover.com/click/here.pl%3fz2473559799%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comKOTA Territory News: GEO Monitor IPO Newsflash: Guizhou Xinbang Pharmaceutical A shareshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3903128&HITNO=13&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3903128&THISHREF=http://c.moreover.com/click/here.pl%3fz2465020963%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3903128&HITNO=13&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3903128&THISHREF=http://c.moreover.com/click/here.pl%3fz2465020963%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comResearch Oracle: Guilinjiqi Pharmaceutical Reports CNY8mn Net Profit for 2009http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3893370&HITNO=14&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3893370&THISHREF=http://c.moreover.com/click/here.pl%3fz2460576514%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3893370&HITNO=14&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shenzhen%20SiBiono%20Gene%20Technologies%20Co.,Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3893370&THISHREF=http://c.moreover.com/click/here.pl%3fz2460576514%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: